Aclaris Therapeutics, Inc. · NASDAQ:ACRS
Schiff Andrew N exercised options for 11,580 Aclaris Therapeutics, Inc. shares (Form 4)
Traded Jun 5, 2026 · Filed Jun 8, 2026
On Jun 5, 2026, Schiff Andrew N (Director) exercised options for 11,580 Aclaris Therapeutics, Inc. shares, leaving 25,540 shares. Filed Jun 8, 2026 (Form 4).
- Options exercised
- 11,580 shares
- Holding after
- 25,540 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Option exercise | 11,580 | 25,540 | Direct |
Source
Related
- Aclaris Therapeutics, Inc.
- Schiff Andrew N
- Aclaris Therapeutics, Inc. shareholders
- Schedule 13G · Frazier Life Sciences Public Fund, L.P. · Sep 21, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Form 4 · Kolbeck Roland Wilhelm · Aug 4, 2026
- Form 4 · Molineaux Christopher P. · Jun 8, 2026
- Form 4 · Milano Vincent · Jun 8, 2026